切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - endothelin receptor - Smoothened - PARP - Voltage-gated Potassium (KV) Channels

18件产品中的 1-10

页面
每页
清除全部
  1. Rucaparib (free base)
    A8893 Rucaparib (free base)
    中文名: 瑞卡帕布
    Target: PARP
    Summary: PARP抑制剂
      ≥16.15 mg/mL
      insoluble in H2O
  2. FR 139317
    B5082 FR 139317
    Target: endothelin receptor
    Summary: 选择性ETA内皮素受体拮抗剂
      Soluble to 100 mM in 1eq. HCl and to 100 mM in DMSO
  3. Psora 4
    B7659 Psora 4
     1 Citation
    Target: Voltage-gated Potassium (KV) Channels
    Summary: Kv1.3阻断剂
      ≥15.75 mg/mL
      insoluble in H2O
  4. Ibutilide Fumarate
    B2278 Ibutilide Fumarate
    中文名: 富马酸伊布利特
    Target: Voltage-gated Potassium (KV) Channels|Voltage-gated Calcium Channels (CaV)|sodium channel
    Summary: III类抗心律失常药物
      ≥25.6 mg/mL
      ≥16.4 mg/mL
  5. LDE225 (NVP-LDE225,Erismodegib)
    B2266 LDE225 (NVP-LDE225,Erismodegib)
     1 Citation
    中文名: 索尼德吉
    Target: Smoothened
    Summary: Smoothened抑制剂
      ≥24.3 mg/mL
      insoluble in H2O
  6. Cisapride
    B1198 Cisapride
    Target: Voltage-gated Potassium (KV) Channels|5-HT4 Receptor
    Summary: 5-HT4受体激动剂
      ≥23.3 mg/mL
      insoluble in H2O
  7. PF-04449913
    B3283 PF-04449913
    中文名: 格拉吉布
    Target: Smoothened
    Summary: Smoothened拮抗剂
      ≥20.15 mg/mL
      insoluble in H2O
  8. ME0328
    A8808 ME0328
    Target: PARP
    Summary: PARP抑制剂
      ≥71.43 mg/mL
      insoluble in H2O
  9. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  10. Cyclopamine
    A8340 Cyclopamine
     1 Citation
    中文名: 环巴胺
    Target: Smoothened
    Summary: Hedgehog (Hh)信号抑制剂
      ≥6.86 mg/mL
      insoluble in H2O

18件产品中的 1-10

页面
每页